Human cytomegalovirus vaccination: progress and perspectives of recombinant gB

Manghera, Avneet and McLean, Gary R. (2016) Human cytomegalovirus vaccination: progress and perspectives of recombinant gB. Future Virology, 11 (6). ISSN 1746-0794

Abstract

A vaccine for Human cytomegalovirus (HCMV) remains a high priority as complications following infection are observed in immunocompromised individuals and in congenitally infected neonates. Numerous preclinical and clinical studies have investigated vaccine strategies ranging from live attenuated preparations, nucleic acid-based approaches and recombinant delivery systems to subunit vaccines. These have defined the importance of both cell-mediated and humoral immunity to viral gB in the control of HCMV infection. This review will cover clinical trials investigating vaccine approaches that have incorporated gB and discuss the future perspectives of the recombinant gB subunit vaccine for HCMV.

Documents
1240:6701
[img]
Preview
FutVirol_2016.pdf - Published Version

Download (1MB) | Preview
Details
Record
Statistics

Downloads

Downloads per month over past year



Downloads each year

View Item View Item